Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab Treatment

NCT04276623 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT04276623
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04276623 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab Treatment
Lead sponsor
UMC Utrecht
Phase
Observational
Overall status
Unknown status
Start date
February 25, 2020
Completion date
December 31, 2023
Enrollment
150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atopic dermatitis